Biodegradable, Polymeric Nanoparticle Delivery Systems for Cancer Therapy
- 1 October 2007
- journal article
- review article
- Published by Taylor & Francis in Nanomedicine
- Vol. 2 (5) , 669-680
Abstract
Nanotechnology has the potential to impact the treatment of cancer significantly. This review will explore how this potential is beginning to be realized through the design of polymeric nanoparticle delivery systems. Current research is focused on developing biocompatible nanoparticles capable of targeting specific cancer markers and delivering imaging and therapeutic agents for the detection and treatment of cancer, resulting in a number of preclinical and clinical applications. More sophisticated nanoparticle designs are now in development, including particles able to release multiple drugs for enhanced treatment efficacy and targeted, multifunctional particles capable of combining imaging and drug release.Keywords
This publication has 86 references indexed in Scilit:
- Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug deliveryBiomaterials, 2007
- Nanoparticle Albumin–Bound Paclitaxel for Metastatic Breast CancerJournal of Clinical Oncology, 2005
- Nanoparticle-Aptamer BioconjugatesCancer Research, 2004
- Folate receptor targeted biodegradable polymeric doxorubicin micellesJournal of Controlled Release, 2004
- Polyacetal−Doxorubicin Conjugates Designed for pH-Dependent DegradationBioconjugate Chemistry, 2003
- Small-scale systems for in vivo drug deliveryNature Biotechnology, 2003
- Pendent Chain Functionalized Polyacetals That Display pH-Dependent Degradation: A Platform for the Development of Novel Polymer TherapeuticsMacromolecules, 2001
- Drugs on TargetScience, 2001
- Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle SizePharmaceutical Research, 1996
- Biodegradable Long-Circulating Polymeric NanospheresScience, 1994